Point prevalence of abnormal thyroid-stimulating hormone during the first trimester of pregnancy in Israel.
Isr Med Assoc J
; 16(9): 564-7, 2014 Sep.
Article
em En
| MEDLINE
| ID: mdl-25351014
ABSTRACT
BACKGROUND:
The prevalence of thyroid dysfunction in early pregnancy in Israel is not known.OBJECTIVES:
To assess the rate of abnormal thyroid-stimulating hormone (TSH) tests in low risk pregnant women attending a community clinic in Israel.METHODS:
We conducted a retrospective analysis of the charts of low risk pregnant women (n = 303) who had undergone a TSH screening during the first trimester of pregnancy at Clalit Health Services Women's Health Centers in Ashkelon and Tel Aviv. TSH of 0.1-2.5 mIU/L during the first trimester was considered to be normal.RESULTS:
The TSH levels ranged from 0.04 to 13.3 mIU/L (median 1.73 mIU/L, mean 1.88 mIU/L).The rate of abnormal TSH was 25.6%, with low TSH 2.3% and high TSH 23.4%. The prevalence of abnormal TSH was not influenced by gravidity (primigravidas versus multigravidas) or place of residence (Ashkelon or Tel Aviv).CONCLUSIONS:
In view of the high prevalence of abnormal TSH (25.6%) in pregnant women in Israel during the first trimester, a universal country-wide screening should be considered.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Complicações na Gravidez
/
Primeiro Trimestre da Gravidez
/
Tireotropina
/
Hipotireoidismo
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
País como assunto:
Asia
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article